Home > Insider Trading > Filing (0001567619-19-002650)

Filing Details

Accession Number:: 0001567619-19-002650
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-07 17:03:49
Reporting Period:: 2019-02-05

Accepted Time:: 2019-02-07 17:03:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184149	W Jonathan Ayers	One Idexx Drive Westbrook ME 04092	Chairman, President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-02-05	15,904	$43.71	1,047,226	No	4	M	Direct
Common Stock	Disposition	2019-02-05	1,718	$203.75	1,045,508	No	4	S	Direct
Common Stock	Disposition	2019-02-05	8,045	$204.75	1,037,463	No	4	S	Direct
Common Stock	Disposition	2019-02-05	6,041	$205.81	1,031,422	No	4	S	Direct
Common Stock	Disposition	2019-02-05	100	$206.14	1,031,322	No	4	S	Direct
Common Stock	Acquisiton	2019-02-06	15,905	$43.71	1,047,277	No	4	M	Direct
Common Stock	Disposition	2019-02-06	8,477	$207.77	1,038,750	No	4	S	Direct
Common Stock	Disposition	2019-02-06	7,428	$208.53	1,031,322	No	4	S	Direct
Common Stock	Acquisiton	2019-02-07	15,905	$43.71	1,047,227	No	4	M	Direct
Common Stock	Disposition	2019-02-07	4,107	$205.53	1,043,120	No	4	S	Direct
Common Stock	Disposition	2019-02-07	8,800	$206.54	1,034,320	No	4	S	Direct
Common Stock	Disposition	2019-02-07	2,998	$207.17	1,031,322	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-02-05	15,904	$0.00	15,904	$43.71
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-02-06	15,905	$0.00	15,905	$43.71
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2019-02-07	15,905	$0.00	15,905	$43.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,810		2019-02-13	No	4	M	Direct
15,905		2019-02-13	No	4	M	Direct
0	2019-02-05		No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	138,000	Indirect	by Ayers Family Trust

Footnotes

Sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the weighted average price of the shares sold ranging from a low of $203.28 to a high of $204.25 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $204.335 to a high of $205.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $205.075 to a high of $206.05 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $207.28 to a high of $208.24 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $208.365 to a high of $208.70 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $205.00 to a high of $205.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $206.015 to a high of $207.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $207.02 to a high of $207.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 58,857 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2012 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.